Markets:

Overview

News

Currencies

International

Treasuries

Annovis Bio, Inc. Common Stock (NY:ANVS)

4.820 +0.730 (+17.85%)

Official Closing Price Updated: 7:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Annovis Bio, Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Annovis Bio Expands Potential Application of ANVS401 to Infectious Diseases with New Preclinical Study

June 08, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - June 8, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a...

Via Newsfile

Topics Intellectual Property

Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich ↗

June 07, 2021

There are better options for investors looking to profit from potential Alzheimer's disease treatments.

Via The Motley Fool

Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab ↗

June 07, 2021

The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.

Via Investor's Business Daily

Annovis Bio to Present at Jefferies Virtual Healthcare Conference 2021

June 03, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - June 3, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Why Is Annovis Bio's Stock Surging Higher Today? ↗

May 21, 2021

Annovis Bio Inc (NYSE:ANVS) shares are trading higher b...

Via Benzinga

68 Biggest Movers From Yesterday ↗

June 02, 2021

Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...

Via Benzinga

Annovis Bio's ANVS401 Improves Speed and Accuracy in Alzheimer's and in Parkinson's Patients

June 01, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - June 1, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's...

Via Newsfile

Annovis Bio Engages Global Executive Search Leader Spencer Stuart to Expand its Board and Management Team

May 28, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 28, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Annovis Bio, Inc. Announces Closing of $50 Million Public Offering

May 27, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 27, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Topics Regulatory Compliance

22 Stocks Moving in Monday's Pre-Market Session ↗

May 24, 2021

Gainers Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 29.3% to $27.25 in pre-market trading. Virgin Galactic’s VSS Unity spacecraft completed its first spaceflight from...

Via Benzinga

54 Biggest Movers From Yesterday ↗

May 26, 2021

Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended...

Via Benzinga

A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises ↗

May 24, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones surged over 100 points in the previous session. Investors are awaiting earnings...

Via Benzinga

Topics Stocks

48 Biggest Movers From Friday ↗

May 24, 2021

Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...

Via Benzinga

5 Stocks To Watch For May 24, 2021 ↗

May 24, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Nordson Corporation (NASDAQ: NDSN) to report quarterly earnings at $1.64 per share on revenue of $...

Via Benzinga

Annovis Bio, Inc. Announces Pricing of Public Offering

May 23, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 23, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Topics Regulatory Compliance

Annovis Bio, Inc. Announces Proposed Public Offering of Common Stock

May 21, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 21, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...

Via Newsfile

Topics Regulatory Compliance

Mid-Afternoon Market Update: Dow Rises 150 Points; VF Corp Shares Fall On Downbeat Earnings ↗

May 21, 2021

Toward the end of trading Friday, the Dow traded up 0.44% to 34,234 while the NASDAQ fell 0.26% to 13,500.91. The S&P also rose, gaining 0.07% to 4,161.93. The U.S. has the...

Via Benzinga

Topics Stocks

Mid-Day Market Update: Nasdaq Turns Lower; Annovis Bio Shares Surge ↗

May 21, 2021

Midway through trading Friday, the Dow traded up 0.71% to 34,327.47 while the NASDAQ fell 0.12% to 13,520.12. The S&P also rose, gaining 0.35% to 4,173.78. The U.S. has the...

Via Benzinga

Topics Stocks

30 Stocks Moving In Friday's Mid-Day Session ↗

May 21, 2021

Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,...

Via Benzinga

Annovis Bio Stock Rockets As Alzheimer's Drug Tops Biogen, Cassava Sciences ↗

May 21, 2021

Annovis Bio said Friday its experimental Alzheimer's and Parkinson's treatment improved cognition in less than a month, leading ANVS stock to soar.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Open Higher; Deere Beats Q2 Estimates ↗

May 21, 2021

Following the market opening Friday, the Dow traded up 0.84% to 34,370.30 while the NASDAQ rose 0.37% to 13,585.45. The S&P also rose, gaining 0.58% to 4,183.17. The U.S. has...

Via Benzinga

Topics Stocks

Annovis Bio's Stock Trading Higher As Alzheimer's/Parkinson's Candidate Shows Cognitive Improvement ↗

May 21, 2021

Annovis Bio Inc (NYSE: ANVS) has announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401, for Alzheimer's disease (AD),...

Via Benzinga

Annovis Bio Announces Positive Phase 2 Data - ANVS401 Improves Cognition in Alzheimer's Disease - Patients' Cognition Improved 3.3 Points on ADAS-Cog11

May 21, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 21, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing...

Via Newsfile

Annovis Bio to Participate in Alzheimer Disease Panel Presented by Maxim Group LLC and Hosted by M-Vest on May 26th, 2021

May 20, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 20, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing...

Via Newsfile

Annovis Bio Announces Positive Phase 2 Data: ANVS401 Significantly Lowers Inflammatory Markers in Parkinson's Patients

May 19, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 19, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing...

Via Newsfile

Annovis Bio Appoints Accomplished Neuroscientist, Dr. Cheng Fang as VP of Research

May 18, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 18, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company...

Via Newsfile

Annovis Bio Files for FDA Orphan Drug Designation for ANVS401 for the Treatment of Alzheimer's Disease in Persons with Down Syndrome

May 13, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 13, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing...

Via Newsfile

Annovis Bio to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 13, 2021

May 11, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 11, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing...

Via Newsfile

64 Biggest Movers From Yesterday ↗

May 11, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....

Via Benzinga

Annovis Bio to Ring Closing Bell at the New York Stock Exchange

May 10, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - May 10, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing...

Via Newsfile

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Annovis Bio, Inc. Common Stock (NY:ANVS)

All News about Annovis Bio, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today